These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Advances in biologic therapy for inflammatory bowel disease]. Sostegni R; Pera A; Daperno M; Rocca R Recenti Prog Med; 2008 Jan; 99(1):10-8. PubMed ID: 18389866 [TBL] [Abstract][Full Text] [Related]
25. The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children. Mutalib M; Borrelli O; Blackstock S; Kiparissi F; Elawad M; Shah N; Lindley K J Crohns Colitis; 2014 Dec; 8(12):1730-4. PubMed ID: 25240477 [TBL] [Abstract][Full Text] [Related]
26. Medical therapy of inflammatory bowel disease for the 21st century. Robinson M Eur J Surg Suppl; 1998; (582):90-8. PubMed ID: 10029372 [TBL] [Abstract][Full Text] [Related]
27. Hospital Admissions, Biological Therapy, and Surgery in Familial and Sporadic Cases of Inflammatory Bowel Disease: A Population-Based Cohort Study 1977-2011. Trier Moller F; Andersen V; Andersson M; Jess T Inflamm Bowel Dis; 2015 Dec; 21(12):2825-32. PubMed ID: 26288000 [TBL] [Abstract][Full Text] [Related]
28. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease. Barrie A; Regueiro M Inflamm Bowel Dis; 2007 Nov; 13(11):1424-9. PubMed ID: 17567879 [TBL] [Abstract][Full Text] [Related]
31. Inflammatory bowel disease surgery in the biologic era. Ferrari L; Krane MK; Fichera A World J Gastrointest Surg; 2016 May; 8(5):363-70. PubMed ID: 27231514 [TBL] [Abstract][Full Text] [Related]
32. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P; Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949 [TBL] [Abstract][Full Text] [Related]
33. Inflammatory bowel disease in the United States from 1998 to 2005: has infliximab affected surgical rates? Cannom RR; Kaiser AM; Ault GT; Beart RW; Etzioni DA Am Surg; 2009 Oct; 75(10):976-80. PubMed ID: 19886148 [TBL] [Abstract][Full Text] [Related]
34. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Frolkis AD; Dykeman J; Negrón ME; Debruyn J; Jette N; Fiest KM; Frolkis T; Barkema HW; Rioux KP; Panaccione R; Ghosh S; Wiebe S; Kaplan GG Gastroenterology; 2013 Nov; 145(5):996-1006. PubMed ID: 23896172 [TBL] [Abstract][Full Text] [Related]
35. Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease. Balderramo D World J Gastroenterol; 2022 Dec; 28(47):6743-6751. PubMed ID: 36620336 [TBL] [Abstract][Full Text] [Related]
37. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study. Jung YS; Han M; Kim WH; Park S; Cheon JH Dig Dis Sci; 2017 Aug; 62(8):2102-2112. PubMed ID: 28593437 [TBL] [Abstract][Full Text] [Related]
38. Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy. Vester-Andersen MK; Prosberg MV; Jess T; Andersson M; Bengtsson BG; Blixt T; Munkholm P; Bendtsen F; Vind I Am J Gastroenterol; 2014 May; 109(5):705-14. PubMed ID: 24642581 [TBL] [Abstract][Full Text] [Related]
39. The burden of surgery and postoperative complications in children with inflammatory bowel disease. Fehmel E; Teague WJ; Simpson D; McLeod E; Hutson JM; Rosenbaum J; Oliver M; Alex G; King SK J Pediatr Surg; 2018 Dec; 53(12):2440-2443. PubMed ID: 30244938 [TBL] [Abstract][Full Text] [Related]